Breaking News

NJII Launches BioCentriq Cell & Gene Therapy Mfg. Center

Process development and clinical manufacturing facility for cell and gene therapies becomes first of its kind located on a U.S. university campus.

By: Contract Pharma

Contract Pharma Staff

The Biopharma Division of the New Jersey Innovation Institute (NJII), an NJIT corporation, has launched BioCentriq as its cell and gene therapy production and manufacturing center. BioCentriq is a process development and clinical manufacturing facility for cell and gene therapies located in Newark, NJ, and the first of its kind to be located on a university campus in the U.S. The Biopharma Division has initiated the qualification and validation process for the BioCentriq facility and its equi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters